Introduction
The interaction of CD40 on B cells with the CD40 ligand (CD40L or CD154) on activated CD4 T cells represents the key event in the initiation of antibody responses to T-dependent antigens (reviewed in 1). Signals via CD40, in conjunction with appropriate cytokines, such as IL-4 and IL-5 in the mouse, then initiate the program of B cell activation, Ig secretion, isotype switching and B cell memory formation. Many of the pioneering studies on the role of CD40 in B cell activation have entailed the use of anti-CD40 mAb: most of these are only weak B cell mitogens, in the absence of costimuli, such as anti-Ig, or cytokines such as IL-4 (2, 3). These findings have led to the generally accepted view that, under physiological conditions, CD40-derived signals act to induce cell cycle progression of B cells that had been pre-activated, say by contact with antigen (reviewed in 2). This concept was supported by findings with CD3-activated primary T cells, (8, 9) , these findings therefore suggested that T cells must reexpress CD154 in a cyclical fashion during the period of T cell-B cell interaction. We therefore concluded that a critical level of IL-2 is required to enable primary T cells, expressing low levels of CD154, to induce B cell activation.
During the course of these experiments we also noted that B cells which had been exposed to activated T cells became markedly responsive to stimulation with normally poorly mitogenic anti-CD40 mAb. This suggested that T cell-B cell interactions set in train an amplification loop which reduces the threshold of signalling via the CD40 receptor. Here we present the results of experiments which analyze the mechanisms involved in this phenomenon.
Methods

Experimental animals
In most experiments unfractionated whole spleen cell (WSC) suspensions or B cells were prepared from spleens of male (CBA/CaϫC57BL10)F 1 mice aged 3-4 months. Some experiments used WSC or B cells from male (xid) or female (normal) (CBA/NϫC57BL10)F 1 mice. All mice were bred under specific pathogen-free conditions.
Reagents
The following mAb were used: hamster anti-CD3 (145-2C11), hamster anti-CD28 (37.51.1, from J. Allison), hamster anti-CD40L (MR1, a gift from R. Noelle), rat anti-Thy-1 (NIMR-1), rat anti-CD8 (YTS 169.4.2.1) and anti-CD4 (YTS 191.1.1.2) (the latter two both obtained from H. Waldmann), rat anti-µ (b.7.6), rat anti-IgD (1.19), rat anti IL-2 (1A12 or S4B6) and rat anti-ovine placental lactogen (Mac-193, from G. Butcher). The following rat anti-CD40 mAb were used: 3/23 (10), DOM185 (from D. Gray), FGK45.5 (from A. Rolink) and 1C10 (from M. Howard) (11) . These mAb were purified on Protein G-Sepharose (Pharmacia, Uppsala, Sweden) and coupled with biotin or FITC by standard methods. Biotinylated or FITCcoupled rat anti-B220 were from PharMingen (San Diego, CA). Mouse IL-2 was from supernatants of a stably transfected cell line kindly provided by F. Melchers (12) . IL-2 bioactivity was titrated using the CTLL indicator cell line, by standard procedures. The production of the soluble CD40L-CD8 fusion protein in Sf9 insect cells has been described elsewhere (13) . The protein was affinity purified from an anti-CD154 column and eluted with Gentle Elution Buffer (Pierce & Warriner, Chester, UK). Lipopolysaccharide (LPS) and normal hamster IgG were from Sigma (Poole, UK)
Preparation of T cells and B cells
Small, dense B cells were prepared from mouse spleen as described previously (6) . In brief, this involved killing T cells by a cocktail of mAb against Thy-1, CD4 and CD8, plus guinea pig complement, followed by Percoll fractionation. These preparations were typically Ͼ90% B220 ϩ , with Ͻ1% T cell contamination. Splenic CD4 ϩ T cells were also prepared as described previously. These were typically Ͼ90% CD4 ϩ , with Ͻ5% B cell contamination.
T cell-B cell co-cultures Purified T cells were cultured (at 10 6 /ml) in supplemented RPMI 1640 medium plus 5% FCS, in flasks coated with anti-CD3 (in PBS, generally at 10 µg/ml, for 24 h at 4°C). Some cultures received in addition soluble anti-CD28 (or normal hamster IgG) at 1-5 µg/ml. In most experiments T cells were stimulated for 12-16 h as indicated. These cells were harvested and then plated into flasks which were uncoated, or had been coated with anti-CD3, as above together with resting B cells (at a ratio of 1:3 T:B). After a further 20-24 h the T cells in these cultures were killed and the B cells were re-cultured with the indicated mitogens. These cultures were labelled with [ 3 H]thymidine (0.5 µCi/well) at the times indicated, harvested 4 h later and incorporation of radiolabel into DNA was determined by standard methods.
WSC
WSC suspensions were freed of erythrocytes by Percoll fractionation and were cultured at 10 6 /ml in flasks coated with 10 µg/ml of anti-CD3 as above (unless otherwise indicated), generally for 24- 
Results
B cells exposed to CD3-activated T cells become hyperresponsive to CD40 stimulation
In our earlier study we showed that B cells harvested from WSC cultures stimulated with anti-CD3 for 24 h, or following contact with CD3/CD28-co-stimulated CD4 T cells, became responsive to IL-2 (6). We subsequently investigated the effects of these priming cultures on the responses of B cells to the anti-CD40 mAb 3/23, which by itself is only a weak mitogen for resting B cells. Figure 1 illustrates the effects of exposing B cells to CD3-stimulated T cells in WSC cultures (priming cultures) for 24 or 48 h on their subsequent proliferative responses to anti-CD40 or anti-µ. Fresh B cells gave only a very weak response to anti-CD40 and a good response to anti-µ, which peaked on day 3 of culture, as expected. Some B cells harvested from WSC cultures after 24 or 48 h were already committed to DNA synthesis, as manifested by the elevated levels of [ 3 H]thymidine uptake at the time they were re-cultured (designated time 0 in Fig. 1 ). These could be naturally pre-activated cells. However, after both 24 and 48 h priming periods, clearly the majority of B cells still required re-stimulation for commitment to DNA synthesis. Re-stimulation with (both optimal and suboptimal concentrations of) anti-CD40 induced a striking proliferative response (some 15-to 25-fold higher than that of fresh, resting B cells), which peaked effects on their responses to anti-µ or LPS (see figure legend) which, although they reached a peak earlier, were only enhanced by~2-fold or barely at all in other experiments (see below). In addition, it should be mentioned that T cells in WSC cultures (unlike purified T cells, see below) do not were re-cultured with purified CD40L-CD8 fusion protein (µg/ml in brackets) or with anti-CD40 (3/23 at 10 µg/ml) and cultures were harvested after 2 days. Fresh B cells cultured with 2 µg/ml CD40L-CD8 which was cross-linked with anti-CD8 gave 52,100 Ϯ 600 c.p.m. require co-stimulation via CD28 to induce B cell responsiveness to IL-2, or hyper-responsiveness to anti-CD40, thereby suggesting that there are sufficient B7 ϩ cells in these cultures.
In order to explore the mechanisms involved in this effect we repeated this experiment, including a variety of blocking mAb to molecules which might play a role. Figure 2(A) shows the results of a representative experiment, where WSC were activated on immobilized anti-CD3 in the presence of anti-CD154 or anti-IL-2. B cells from these cultures were then recultured with anti-CD40 (either 3/23 or FGK45.5, which is also weakly mitogenic for resting B cells), IL-2 or anti-µ (see figure legend). It is clear that blocking the CD154-CD40 interaction substantially (but not completely) abrogated the priming effect. A neutralizing anti-IL-2 mAb [but not anti-IL-4, or an irrelevant isotype-matched control (Mac-193); data not shown] also suppressed the heightened responsiveness to both anti-CD40 mAb tested, but to a lesser degree. Anti-IL-2 had a much more dramatic effect on the induction of IL-2 responsiveness in B cells, in agreement with our earlier findings (6) . In additional experiments (not shown) we also found that the addition of anti-LFA-1 substantially abrogated both the induction of IL-2 responsiveness and the heightened responsiveness to anti-CD40. These results therefore suggest that both CD154-CD40 interactions and IL-2 contribute to this priming effect, a conclusion which is strengthened by further experiments presented below.
We next wished to determine if this priming effect could also be observed in response to a soluble construct of CD40L, which is known to be poorly mitogenic for resting B cells, unless secondarily cross-linked (14, 15) . The results in Fig. 2(B) show that primed B cells respond much more vigorously to stimulation with CD40L-CD8 fusion protein than fresh B cells, in the absence of secondary cross-linking: the proliferative response of the latter is, as expected, markedly enhanced by cross-linking the fusion protein with anti-CD8 (see figure  legend) .
Flow cytometric analyses of B cells harvested from these CD3-stimulated WSC cultures revealed that they have the typical phenotype of activated cells, in that they are enlarged and express uniformly high levels of MHC Class II, and are virtually all CD25 and CD86 ϩ . In addition, exposure of B cells to activated T cells for 24 h leads to a~5-fold increase in their levels of CD40, which is not simply due to cellular enlargement, since the levels of B220 on these cells only increased some 2-fold (data not shown). The up-regulation of CD40 was substantially blocked by including anti-CD154 in the priming cultures and is therefore dependent on CD40/ CD154 interactions. Addition of neutralizing mAb against IL-2 or IL-4 had variable and far less dramatic inhibitory effects.
The induction of IL-2 responsiveness in B cells requires more extensive CD3 cross-linking than the elicitation of heightened responsiveness to anti-CD40
We subsequently investigated the effects of differing doses of immobilized anti-CD3 in WSC on the induction of hyperresponsiveness to CD40 stimulation. Hence, WSC cultures were set up in flasks coated with 0.1, 1 or 10 µg/ml anti-CD3 and B cells were re-cultured after 24 h. The results in Fig. 3 show that reducing the concentration of anti-CD3 used in the priming cultures reduced both responses to anti-CD40 and IL-2. However, it is clear that suboptimal concentrations of anti-CD3 were more effective in eliciting an enhanced response to anti-CD40 than for inducing B cells to become IL-2 responsive. This indicates that priming of B cells for CD40 responses requires a lower level of TCR cross-linking than the elicitation of IL-2 responsiveness, for unknown reasons.
Co-stimulation of B cells via their antigen receptor further enhances their responsiveness to anti-CD40
In an attempt to mimic the effects of antigen in this system, similar experiments were performed, but with the addition of anti-Ig to the WSC cultures stimulated with anti-CD3. Figure 4 shows that anti-IgD induced a 20-30% increase in the levels of proliferation induced by anti-CD40, but had no effects on the responses of B cells to IL-2. Interestingly, the addition of exogenous IL-2 during the priming culture caused a similar level of enhancement of responses induced by suboptimal concentrations of anti-CD40 and also significantly enhanced proliferation induced by IL-2. This suggests that the concentrations of IL-2 may be limiting in these cultures, at least in some experiments (see below).
B cells from xid mice become responsive to anti-CD40 stimulation following exposure to activated T cells CBA/N mice carrying the xid mutation in Bruton's tyrosine kinase mount poor primary responses to T-dependent antigens in vivo (16, 17) . In vitro, B cells from these animals do Fig. 4 . Effects of co-stimulation via the antigen receptor, or the addition of IL-2, on induction of hyper-responsiveness to anti-CD40. WSC were stimulated with immobilized anti-CD3, in the presence or absence of anti-IgD (10 µg/ml) or IL-2 (100 U/ml). T cells were depleted after 24 h and the recovered B cells, or fresh B cells, were re-cultured with the indicated concentrations of 3/23 anti-CD40 (µg/ ml in brackets) or IL-2 (U/ml in brackets). Cultures were harvested after 48 h re-culture.
not proliferate in response to a variety of mitogens, including anti-Ig and three out of four anti-CD40 mAb (18) (19) (20) . It was therefore of interest to determine the effects of T-dependent activation of xid B cells on their responses to CD40 stimulation. Figure 5 shows that B cells harvested from CD3-stimulated WSC cultures from xid mice responded as vigorously as those from normal littermates when re-stimulated with anti-CD40, although their responses to IL-2 were lower. Interestingly, preactivated xid B cells did not become responsive to anti-µ, but gave markedly enhanced responses to LPS, whereas pre-activation had little effect on the responses of normal B cells to these mitogens. B cells from CBA/N mice survive poorly in culture, because they have lower levels of the key anti-apoptotic protein Bcl-2 (21, 22) . We therefore examined the effects of T-dependent activation of xid and normal B cells on their survival, by flow cytometric analyses of propidium iodide-stained cells. The results (not shown) revealed that B cells harvested from WSC cultures of both wild-type and xid mice survived significantly longer than fresh B cells, especially if re-stimulated with either IL-2 or anti-CD40.
CD3/CD28-co-stimulated T cells are more effective than CD3-stimulated T cells at inducing hyper-responsiveness to CD40 stimulation
The results obtained thus far suggested that the observed priming effect was induced by a combination of CD40-mediated signals and IL-2. Since it is well-established that optimal IL-2 production by T cells requires co-stimulation via CD28 (reviewed in 23), we next studied the capacity of purified CD4 T cells to activate B cells. These T cells were pre-stimulated via CD3 alone, or via CD3 and CD28 for 16 h. They were then re-cultured on immobilized anti-CD3 with B cells for 20 h, in the presence or absence of mAb to CD40L, or to IL-2. Subsequently, the T cells were depleted and the B cells were re-cultured with various mitogens (Fig. 6 ). As we described previously (6) , only CD3/CD28-co-stimulated T cells effectively induce IL-2 responsiveness in B cells and this effect is significantly abrogated by blocking CD40L-CD40 interactions or by neutralizing IL-2. Figure 7(A) shows that, in addition, T cells pre-activated via CD3 alone were significantly less effective than co-stimulated T cells in priming B cells to respond to anti-CD40 stimulation. The capacity of co-stimulated T cells to prime B cells to respond to anti-CD40 was completely blocked by the inclusion of anti-CD40L and significantly inhibited by neutralizing IL-2.
In a second similar experiment B cells were cultured with CD3-or CD3/CD28-pre-activated CD4 T cells on immobilized anti-CD3 for 20 h, in the presence or absence of exogenous IL-2. The T cells were then depleted and the recovered B cells, or fresh B cells, were re-cultured with various mitogens (Fig. 7) . In this experiment, fresh B cells gave a higher response to anti-CD40 than in previous ones (possibly due to the use of a different batch of FCS); however, exposure of B cells to CD3-primed T cells had minimal effects on their response to anti-CD40 and did not render them IL-2 responsive, as we described previously (6) . In contrast, B cells harvested from co-cultures with CD3/CD28-pre-activated T cells again gave a significantly greater response to anti-CD40 and responded well to IL-2, as expected. Co-cultures of CD3-primed T cells and B cells which were supplemented with IL-2 yielded B cells which responded as well to either anti-CD40, or IL-2, as those harvested from co-cultures with CD3/CD28-pre-activated T cells. The addition of IL-2 to the latter co-cultures did not affect B cell responses to anti-CD40, but further enhanced their responsiveness to IL-2 (an effect not seen in most experiments). These results therefore reinforce the conclusion that CD40L-CD40 interactions, in conjunction with IL-2, lead both to IL-2 responsiveness and hyperresponsiveness to CD40 stimulation in B cells.
Discussion
The induction of proliferation in quiescent B cells via ligation of CD40 clearly depends critically on the level of cross-linking of the receptor. Hence, CD154-transfected cell lines or preactivated T cell clones, which express high levels of CD154, can effectively activate B cells, in the absence of exogenous co-stimuli (24) (25) (26) . Soluble constructs of CD154 are poorly mitogenic, unless secondarily cross-linked (14, 15) . Similarly, primary T cells activated via CD3 alone, which express some 10-to 20-fold less CD154 than T cell clones, are poor B cell activators, in the absence of co-stimuli, such as IL-2, or unless the B cells have been pre-activated, by anti-Ig, for example (4-6). Most anti-CD40 mAb also elicit minimal levels of DNA synthesis in resting B cells, in the absence of co-stimuli, such as anti-Ig, or appropriate cytokines, or unless they are presented on a matrix, as provided by CD32-transfected fibroblasts, for example (27) . The data we present here indicate that when naive B cells encounter CD3-activated T cells in WSC cultures, or CD3/CD28-co-stimulated T cells, this leads to (at least two) profound changes in their responsiveness. Firstly, the cells become responsiveness to IL-2 (6). Secondly, B cells activated in this T-dependent fashion respond much more vigorously than naive cells to re-stimulation via CD40, even when stimulated with suboptimal amounts of anti-CD40 or with a soluble CD40L-CD8 fusion protein (Figs 1 and 2) . It is noteworthy that this priming effect is seemingly specific for responses elicited by engaging CD40, since activation of B cells in this fashion has much less dramatic effects on their responses to anti-Ig or LPS (Figs 1  and 5) . The powerful nature of the effect is underscored by the fact that B cells from xid mice, which do not proliferate at all when stimulated with most anti-CD40 mAb, respond vigorously after being exposed to activated T cells (Fig. 5) .
The induction of this heightened responsiveness is largely dependent on the interaction of CD40 with CD154, since it is substantially abrogated by blocking the interaction of these two molecules (Figs 2A and 6 ). However, it is clear that other T cell-derived stimuli also play a significant role, most notably IL-2, which apparently acts in synergy with CD154. Hence, purified CD4 T cells activated via CD3 alone are much less effective at enhancing CD40 responsiveness in B cells than CD3/CD28-co-stimulated cells (Fig. 6 ), even though both populations of T cells re-express similar levels of CD154 when re-stimulated via CD3 (6) . Addition of IL-2 to co-cultures of CD3-primed T cells with B cells rendered these T cells competent at both inducing IL-2 responses in B cells and in enhancing their responsiveness to CD40 stimulation (Fig. 7) . It is possible that under physiological conditions, other T cellderived cytokines (such as IL-4) may play a role as well, although in our hands neutralizing anti-IL-4 mAb had no effect. In addition, co-stimulation of B cells with anti-Ig during the priming cultures further enhances their subsequent responses to anti-CD40 (Fig. 4) , thereby suggesting that signals via the B cell antigen receptor can also contribute to lowering the threshold for CD40 stimulation. We have attempted to mimic the effects of activated T cells by priming B cells with soluble CD40L-CD8, together with IL-2. The results of this experiment were, however, inconclusive, since it proved impossible to wash the fusion protein off the cells: in consequence, background levels of [ 3 H]thymidine uptake were markedly elevated in cultures which were not re-stimulated (data not shown).
T-dependent B cell activation in the present system also leads to a~5-fold increase in the levels of CD40 expressed by B cells (not shown). This is in agreement with the findings of others using different B cell mitogens, such as anti-Ig plus IL-4 or LPS (28, 29) . However, we consider it unlikely that the observed effects on B cell proliferation are simply due to the increased levels of CD40 on activated B cells, for the following reasons. Firstly, the magnitude of the increases in proliferation of B cells activated by T cells far exceed the increases in the levels of CD40 these cells express. Secondly, B cells from transgenic mice which express some 10-fold more CD40 than wild-type cells do not proliferate more vigorously when cultured with anti-CD40 (N. van Emmerik and G. G. B. Klaus, unpublished data). Rather we believe that some fundamental biochemical changes occur in the signal transducing machinery associated with CD40 as a result of B cell activation. There is indeed evidence for this concept, since Uckun et al. (30) found that engagement of CD40 on buoyant (i.e. pre-activated), but not resting human B cells led to inositol phospholipid hydrolysis and protein tyrosine kinase activation Downloaded from https://academic.oup.com/intimm/article-abstract/11/1/71/693183 by guest on 18 January 2019
We have consistently failed to detect protein tyrosine kinase activation following the stimulation of small dense B cells with anti-CD40 (data not shown), whilst anti-CD40 induces robust protein tyrosine phosphorylation in human germinal centre B cells (31) .
The precise nature of the second messenger systems invoked by ligation of CD40 is still somewhat confused and may indeed vary according to the state of maturity and/or activation of the target cells (reviewed in 32). However, it is clear that signalling via CD40 involves several members of the TNF receptor-associated factors (TRAF) protein family, which link the receptor to downstream events, such as the induction of NF-κB (reviewed in 33). The present results suggest that the biochemical mechanisms which lead to the establishment of IL-2 responsiveness and hyper-responsiveness to CD40 stimulation in B cells may well be similar, since both apparently depend on a combination of CD40-mediated signals and IL-2 itself, acting in synergy (Figs 2, 6 and 7). However, there are apparent differences, as illustrated by the requirements for more extensive TCR cross-linking for the induction of IL-2 responses in cells (Fig. 3) , a phenomenon which deserves further investigation. The IL-2 receptor is coupled to two members of the JAK family of protein tyrosine kinases JAK1 and JAK3, which act on two of the STAT family of transcription factors (STAT3 and STAT5) (reviewed in 34). It may therefore be relevant that both JAK3 and STAT5 are up-regulated in human B cells stimulated via CD40 (35) . In addition, Hanissian and Geha (36) have recently shown that JAK3 is associated with CD40, and that it and STAT3 become activated following ligation of CD40 on a human B cell line, although these results were not confirmed by another group (37) .
We therefore postulate that the initial encounter of B cells with activated T cells sets in train an amplification loop, which not only induces B cells to become IL-2 responsive, but also markedly reduces the threshold for their activation via the CD40 receptor. This effect is likely to play an important role during the initiation of antibody responses, when T cells only express low levels of CD154, which are by themselves insufficient to induce full-blown B cell activation. Other amplification mechanisms may well be important at this stage of the response, as well. For example, Jaiswal and Croft (38) have shown that the interaction of pre-activated (i.e. effector) T cells with resting B cells, presenting a cognate peptide, leads to the expression of higher levels of CD154, than the interaction of naive T cells with resting B cells. In addition, CD40 ligation reduces the threshold of B cell activation via their antigen receptors (3). Taken together, it is evident that the immune system has evolved multiple amplification mechanisms to maximize responses to antigen, which probably play their most important roles during the early phases of antibody responses. Our future experiments will address the biochemical mechanisms involved in the priming effects we have described here and also how T cell-B cell interactions affect components of the cell cycle regulatory machinery in B lymphocytes.
